MedPath

To study the effect of steroid use during treatment of severe Covid 19 on steroid axis function during 6 month post covid period.

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2021/05/033799
Lead Sponsor
Prof Dr Jayanthy Ramesh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

diagnosed moderate or severe Covid 19 by RTPCR or Rapid Antigen Test(RAT) or HRCT thorax, admitted, treated and discharged from CSR Block, King George Hospital.

Those patients who were hospitalised and have received steroid treatment for less than 14days.

Those who give consent to participate in the study

Exclusion Criteria

Pregnant individuals

Patients receiving glucocorticoids for any indication prior to hospital admission

K/c/o primary/secondary adrenal insufficiency/ cortisol excess states

Patients with Chronic kidney disease, Chronic liver disease, Coronary artery disease , Cerebrovascular accident

Smokers/ Chronic alcoholism

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hypothalamo pituitary axis suppression, demonstrated by <br/ ><br> ACTH stimulated cortisol less than 18 mcg/dlTimepoint: 3 months and 6 months
Secondary Outcome Measures
NameTimeMethod
to coreelate between disease severity and HPA axis suppressionTimepoint: 3 month and 6 month
© Copyright 2025. All Rights Reserved by MedPath